Actinomycosis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Actinomycosis Classification and external resources | |
| A patient with Actinomycosis on the right side of the face. | |
| ICD-10 | A42. |
| ICD-9 | 039 |
| DiseasesDB | 145 |
| eMedicine | med/31 |
| MeSH | D000196 |
|
WikiDoc Resources for Actinomycosis | |
|
Articles | |
|---|---|
|
Most recent articles on Actinomycosis Most cited articles on Actinomycosis | |
|
Media | |
|
Powerpoint slides on Actinomycosis | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Actinomycosis at Clinical Trials.gov Trial results on Actinomycosis Clinical Trials on Actinomycosis at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Actinomycosis NICE Guidance on Actinomycosis
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Actinomycosis Discussion groups on Actinomycosis Patient Handouts on Actinomycosis Directions to Hospitals Treating Actinomycosis Risk calculators and risk factors for Actinomycosis
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Actinomycosis | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Actinomycosis (ak-tuh-nuh-my-KOH-sihs), is a rare infectious bacterial disease of humans generally caused by Actinomyces israelii, A. gerencseriae and Propionibacterium propionicus, though the condition is likely to be polymicrobial.[1] Characterized by the formation of painful abscesses in the mouth, lungs, or digestive organs, actinomycosis abscesses grow larger as the disease progresses, often over a period of months. In severe cases, the abscesses may penetrate the surrounding bone and muscle to the skin, where they break open and leak large amounts of pus.
Actinomycosis occurs in cattle and other animals as a disease called lumpy jaw. This name refers to the large abscesses that grow on the head and neck of the infected animal.
In 1877 pathologist Otto Bollinger described the presence of Actinomyces bovis in cattle, and shortly afterwards, James Israel discovered Actinomyces israelii in humans. In 1890 Eugen Bostroem isolated the causative organism from a culture of grain, grasses, and soil. After Bostroem's discovery there was a general misconception that actinomycosis was a mycosis that affected individuals who chewed grass or straw.
Causative organism
Actinomycosis is primarily caused by any of several members of the bacterial genus Actinomyces. These bacteria are generally anaerobes.[1] Actinomyces spp. normally live in the small spaces between the teeth and gums, causing infection only when they can multiply freely in anoxic environments. The three most common sites of infection are decayed teeth, the lungs, and the intestines.
Since Actinomyces bacteria are generally sensitive to penicillin, it is frequently used to treat actinomycosis.
Pathophysiology & Etiology
- 6 species cause disease in humans:
- A. israelii
- A. Naeslundii
- A. odontolyticus
- A. viscosus
- A. Meyeri
- A. gerencseriae
- Gram positive filamentous rod
- Sulfur Granules
- Actinomyces from within, Nocardia from without
- Generally low pathogenicity and cause disease only in the setting of antecedent tissue injury
Symptoms
- Cervicofacial Actinomycosis (55%)
- Thoracic Actinomycosis
- Lungs
- Pleura
- Mediastinum
- Chest wall (aspiration, extension of cervicofacial disease, transdiaphragmatic or retroperitoneal spread)
- Clinical picture of tuberculosis (TB) or malignancy
- Abdominal and Pelvic Actinomycosis
- Following:
- Penetrating trauma
- Gut perforation
- Surgical manipulation
- Ileocecal predilection
- Confused with:
- TB
- Ameboma
- Chronic appy
- Regional enteritis
- Carcinoma
- Intrauterine devices (IUD’s)
- Confused with:
- Following:
- Central Nervous System (CNS)
Pharmacotherapy
- In vitro susceptible to:
- Penicillin
- Chloramphenicol
- The tetracyclines
- Erythromycin
- Clindamycin
- Imipenem
- Streptomycin
- The cephalosporins
- Prolonged treatment (6-12 months)
Surgery and Device Based Therapy
- Surgery often required for disease of the chest, abdomen, pelvis, and central nervous system (CNS)
References
External links
Acknowledgements
The content on this page was first contributed by: Dr. Steve Wiviott
WikiDoc Research Resources for Actinomycosis (Click show to right to view) | |
|---|---|
| Articles on Actinomycosis | Most recent articles on Actinomycosis • Most cited articles on Actinomycosis • Review articles on Actinomycosis • Articles on Actinomycosis in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Actinomycosis | Powerpoint slides on Actinomycosis • Images of Actinomycosis • Photos of Actinomycosis • Podcasts & MP3s on Actinomycosis • Videos on Actinomycosis |
| Evidence Based Medicine Regarding Actinomycosis | Cochrane Collaboration on Actinomycosis • Bandolier on Actinomycosis • TRIP on Actinomycosis |
| Cost Effectiveness of Actinomycosis | Cost Effectiveness of Actinomycosis |
| Clinical Trials Involving Actinomycosis | Ongoing Trials on Actinomycosis at Clinical Trials.gov • Trial results on Actinomycosis • Clinical Trials on Actinomycosis at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Actinomycosis | US National Guidelines Clearinghouse on Actinomycosis • NICE Guidance on Actinomycosis • NHS PRODIGY Guidance • FDA on Actinomycosis • CDC on Actinomycosis |
| Textbook Information on Actinomycosis | Books and Textbook Information on Actinomycosis |
| Pharmacology Resources on Actinomycosis | Dosing of Actinomycosis • Drug interactions with Actinomycosis • Side effects of Actinomycosis • Allergic reactions to Actinomycosis • Overdose information on Actinomycosis • Carcinogenicity information on Actinomycosis • Actinomycosis in pregnancy • Pharmacokinetics of Actinomycosis • |
| Genetics, Pharmacogenomics, and Proteinomics of Actinomycosis | Genetics of Actinomycosis • Pharmacogenomics of Actinomycosis • Proteomics of Actinomycosis |
| Newstories on Actinomycosis | Actinomycosis in the news • Be alerted to news on Actinomycosis • News trends on Actinomycosis |
| Commentary on Actinomycosis | Blogs on Actinomycosis |
| Patient Resources on Actinomycosis | Patient resources on Actinomycosis • Discussion groups on Actinomycosis • Patient Handouts on Actinomycosis • Directions to Hospitals Treating Actinomycosis • Risk calculators and risk factors for Actinomycosis |
| Healthcare Provider Resources on Actinomycosis | Symptoms of Actinomycosis • Causes & Risk Factors for Actinomycosis • Diagnostic studies for Actinomycosis • Treatment of Actinomycosis |
| Continuing Medical Education (CME) Programs on Actinomycosis | CME Programs on Actinomycosis |
| International Resources on Actinomycosis | Actinomycosis en Espanol • Actinomycosis en Francais |
| Business Resources on Actinomycosis | Actinomycosis in the Marketplace • Patents on Actinomycosis |
| Informatics Resources on Actinomycosis | List of terms related to Actinomycosis |
de:Aktinomykose gl:Actinomicose hr:Aktinomikoza nl:Actinomycosesr:Актиномикоза fi:Aktinomykoosi uk:Актиномікоз
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

